Inflammatory breast cancer IHC: Immunohistochemistry Mb: Megabase NGS: Next-generation sequencing non-IBC: Non-inflammatory breast cancer SNV: Single nucleotide variant TCGA: The Cancer Genome Atlas TMB: Tumor mutational burden TN: Triple-negative tNGS: Targeted next-generation sequencing ...
Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is keyThe originally published article contained an error in Table 1, in which two neoadjuvant clinical trials (NCT02876107 and NCT03101748) were not included. This omission has been corrected in the online and print ...
Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience. Abstract Between July 1988 and May 1990, we treated 45 women with newly diagnosed, unilateral, nonmetastatic, inflammatory breast cancer with an intensive neoadjuvant chemotherapy ...
1. Lee BJ, Tannenbaum EN: Inflammatory carcinoma of the breast. Surg Gynecol Obstet 39:580-595, 1924.2. Hance KW, Anderson WF, Devesa SS, et al: Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results program at the National Cancer Inst...
The natural history of inflammatory breast cancer and the recent advances in its management were reviewed.The English medical literature from 1924 to 1990 was reviewed using the Cancerline and Medline retrieval systems, and through a manual review of bibliographies of identified articles.The majority ...
Inflammatory Breast Cancer (IBC) is a highly aggressive malignancy with distinct clinical and histopathological features whose molecular basis is unresolved. Here we describe a human IBC cell line, A3250, that recapitulates key IBC features in a mouse xenograft model, including skin erythema, diffuse...
Inflammatory cancer of the breast is a rare type of breast cancer that spreads rapidly. It causes red, inflamed skin on the breast, not lumps in the breast.
Inflammatory breast cancer (IBC) is a rare and aggressive form ofbreast cancerthat has spread to the breast skin. About 1% to 5% of all breast cancer cases are IBC.1 Healthcare providers diagnose IBC at advanced stages, including stages 3 and 4, since cancer cells have grown into the skin...
Breast cancer patients have an increased risk of cardiometabolic disease and for many patients, adjuvant therapy causes an altered lipid profile, insulin resistance and inflammation. Previous follow-up studies are inconclusive regarding the duration of therapy-induced inflammation. We examined the acute an...
and cancer. Moreover,atherosclerosis, the main cause ofcoronary arterydisease, is aninflammatory diseasein which immune mechanisms interact with metabolicrisk factorsto initiate, propagate, and activate lesions in thearterial tree[35]. Atherosclerosis and inflammation share similar basic mechanisms involving...